PR Newswire Asia's news > Medical/Pharmaceuticals

 < Previous page   |   Detail   |   Print    Next page > 
     
2026 Tang Prize in Biopharmaceutical Science Awarded to Three Pioneers of Cellular Immunotherapy
2026-06-16T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
DIMERIX EXCLUSIVELY LICENSES DMX-200 IN GREATER CHINA, SOUTH KOREA AND SOUTHEAST ASIA TO EVEREST MEDICINES
2026-06-16T    Health Care/Hospital   Medical/Pharmaceuticals 
Informa Markets and Thailand's Health Ministry Join Forces To Deliver a Successful Edition of International Healthcare Week 2026 in Bangkok
2026-06-16T    Health Care/Hospital   Medical/Pharmaceuticals 
DIMERIX EXCLUSIVELY LICENSES DMX-200 IN GREATER CHINA, SOUTH KOREA AND SOUTHEAST ASIA TO EVEREST MEDICINES
2026-06-16T    Health Care/Hospital   Medical/Pharmaceuticals 
Minghui Pharmaceutical Presents Compelling Phase I/II Results for MHB018A, a Novel Subcutaneous Anti-IGF-1R Antibody for Thyroid Eye Disease, in an Oral Presentation at ENDO 2026, the Endocrine Society's Annual Meeting
2026-06-16T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Revolutionizing Cancer Treatment: MAaGI Medical's "i" Series Multimodal Tumor Therapy Technique Globally Debuted
2026-06-15T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Harbour BioMed and BioMap Jointly Initiate MegaStream TechBio: A Leading Global Drug Development Platform Joins Forces with Premier Life Science Foundation Models to Set New Benchmarks for AI-Driven Complex Biologics R&D
2026-06-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Halia Therapeutics Receives FDA Fast Track Designation for Ofirnoflast (HT-6184) in Lower-Risk Myelodysplastic Syndromes
2026-06-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Six Regional Organisations Sign MoU to Strengthen Asia's Dengue Response as Cases Rise
2026-06-15T    Education   Health Care/Hospital   Infectious Disease Control   Medical/Pharmaceuticals 
Bambusa Therapeutics Presents Positive Preliminary Multiple Ascending Dose Phase 1 Data for BBT002 at the European Academy of Allergy & Clinical Immunology (EAACI) Annual Congress 2026
2026-06-15T    Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

 

88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2026
Suntek Computer Systems Limited.
All rights reserved